Latest Blog

Feel Therapeutics highlighted in IQVIA's 2022 ESG report

Feel Therapeutics was highlighted in IQVIA's recently published 2022 ESG Report, as one of the promising startups identified in the IQVIA Innovation Hub. Read more

Feel Therapeutics Selected to Join Johnson & Johnson Innovation–JLABS

Feel Therapeutics Selected to Join Johnson & Johnson Innovation–JLABS to Catalyze their Vision of Digital Precision Medicine in Mental Health. Read more

Feel Therapeutics Granted US Patent for its Emotion Detection Technology

Feel Therapeutics Granted US Patent for its Emotion Detection Technology. Read more

Feel Therapeutics Launches its Digital Precision Medicine Platform

Feel Therapeutics Launches its Ground-breaking Digital Precision Medicine Platform to Enable the Era of Precision Neuroscience and Psychiatry. Read more

Feel unveils a cutting-edge Wearable Device for Emotional & Mental Health

Feel unveils a cutting-edge Wearable Device paired with AI for Emotional & Mental Health. Read more

Feel Therapeutics Granted 2nd Patent for Emotion AI Technology

.jpg)

Feel Therapeutics Granted 2nd Patent for Emotion AI Technology. Read more

Are Smartphone Sensors reliable Markers of Mental Health Status?

Are Smartphone Sensors reliable Markers of Mental Health status? Read more

Why we need Wearable Technology in Mental Health

.jpg)

Why we need Wearable Technology in Mental Health. Read more

Feel Therapeutics Brings Michel Vounatsos as Chairman Of The Advisory Board

Feel Therapeutics Brings Michel Vounatsos as Chairman Of The Advisory Board, and Secures New Funding to Advance Digital Precision Medicine for Mental Health. Read more

Digital Precision Medicine for Mental Health: A New Frontier towards Precision Psychiatry

.jpg)

Digital Precision Medicine for Mental Health: A New Frontier towards Precision Psychiatry. Read more

Study Results of their Proprietary Digital Precision Medicine Platform

.png)

Feel Therapeutics Announces Study Results of their Proprietary Digital Precision Medicine Platform, Validating Promising Impact on Mental Health Conditions. Read more

George Eleftheriou, CEO of Feel Therapeutics, to Speak at JLABS Symposium

George Eleftheriou, CEO of Feel Therapeutics, to Speak at Johnson & Johnson Innovation - JLABS Symposium for Precision Medicine. Read more